| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $167.0M | — | +97.6% |
| R&D Expense | $15.6M | — | -10.4% |
| SG&A Expense | $45.6M | — | +142.0% |
| Operating Income | $41.9M | — | +419.6% |
| Pre-tax Income | $38.1M | — | +6075.4% |
| Income Tax | -$6.9M | — | -664.6% |
| Net Income | $44.9M | — | +5581.1% |
| EPS (Basic) | $0.21 | — | +2200.0% |
| EPS (Diluted) | $0.18 | — | +1900.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.46B | +22.2% | — |
| Accounts Receivable | $65.3M | +25.6% | — |
| Current Assets | $2.23B | +19.6% | — |
| Total Assets | $2.73B | +17.8% | — |
| Current Liabilities | $1.17B | +38.6% | — |
| Long-term Debt | $867.3M | +55.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$37.8M | — | +73.0% |
| Investing Cash Flow | -$53.6M | — | -232.3% |
| Financing Cash Flow | $361.2M | — | +84.3% |
| Total Liabilities | $1.44B | +33.2% | — |
| Stockholders' Equity | $1.29B | +5.1% | +250.6% |